Pillstats
Rx only · Capsule · Oral

Cevimeline Hydrochloride

Brands: Cevimeline · Evoxac · Cevimeline Hydrochloride

14 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US18 NDCs
14 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers14 labelers
Packages34
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.462$0.924$1.39$1.85Dec 2025Apr 2026Jul 2026
$1.565
Latest avg · Jul 1, 2026
-1%
Since Dec 17, 2025
14
Active US suppliers
41%
Top-2 supplier share*

Who makes it14 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager10SUPPLYING
Advagen Pharma Ltdunknown4SUPPLYING
Asclemed USA, Inc.unknown4SUPPLYING
Aurobindo Pharma Limitedunknown3SUPPLYING
Novel Laboratories, Inc.unknown3SUPPLYING
Cosette Pharmaceuticals, Inc.unknown2SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown2SUPPLYING
Macleods Pharmaceuticals Limitedunknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Rising Pharma Holdings, Inc.unknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
Viona Pharmaceuticals Incunknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown0SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.